Written by Odile Viltart and Virginie Tolle, PhD – INSERM UMR894 – Centre de Psychiatrie et Neurosciences, Paris, FRANCE

Metabolic syndrome (MetS) is the constellation of risks namely abdominal obesity, insulin-resistance, type 2 diabetes, dyslipidemia and arterial hypertension.  In this article, our experts are reviewing a brief history of metabolic syndrome, the importance of biomarkers for the diagnosis and prognosis of nutritional/metabolic disorders and the challenge of identifying new biomarkers